Literature DB >> 21922294

Chronic hypoxia impairs extracellular nucleotide metabolism and barrier function in pulmonary artery vasa vasorum endothelial cells.

Gennady G Yegutkin1, Mikko Helenius, Elzbieta Kaczmarek, Nana Burns, Sirpa Jalkanen, Kurt Stenmark, Evgenia V Gerasimovskaya.   

Abstract

Vascular remodeling plays a pivotal role in a variety of pathophysiological conditions where hypoxia and inflammation are prominent features. Intravascular ATP, ADP and adenosine are known as important regulators of vascular tone, permeability and homeostasis, however contribution of purinergic signalling to endothelial cell growth and angiogenesis remains poorly understood. By using vasa vasorum endothelial cells (VVEC) isolated from pulmonary artery adventitia of control and chronically hypoxic neonatal calves, these studies were aimed to evaluate the effect of hypoxia on biochemical and functional properties of microvascular endothelial network at the sites of angiogenesis. In comparison with normoxic controls, VVEC from hypoxic animals are characterized by (1) drastically impaired nucleoside triphosphate diphosphohydrolase-1 (NTPDase-1/CD39) and ecto-5'-nucleotidase/CD73 activities with respective increases in basal extracellular ATP and ADP levels (2) higher proliferative responses to low micromolar concentrations of ATP and ADP; and (3) enhanced permeability and disordered adenosinergic control of vascular barrier function (measured as a paracellular flux of 70 kDa fluorescein isothiocyanate-dextran). Together, these results suggest that unique pattern of purine-mediated angiogenic activation and enhanced leakiness of VVEC from chronically hypoxic vessels may be defined by disordered endothelial nucleotide homeostasis at sites of active neovascularization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922294      PMCID: PMC3940057          DOI: 10.1007/s10456-011-9234-0

Source DB:  PubMed          Journal:  Angiogenesis        ISSN: 0969-6970            Impact factor:   9.596


  41 in total

1.  Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5'-nucleotidase/CD73-dependent mechanism.

Authors:  Tiina Henttinen; Sirpa Jalkanen; Gennady G Yegutkin
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

Review 2.  Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation.

Authors:  M J L Bours; E L R Swennen; F Di Virgilio; B N Cronstein; P C Dagnelie
Journal:  Pharmacol Ther       Date:  2006-06-19       Impact factor: 12.310

3.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

4.  Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions.

Authors:  G G Yegutkin; T Henttinen; S Jalkanen
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

5.  Control of cell membrane ecto-ATPase by oligomerization state: intermolecular cross-linking modulates ATPase activity.

Authors:  J G Stout; T L Kirley
Journal:  Biochemistry       Date:  1996-06-25       Impact factor: 3.162

6.  Identification and characterization of CD39/vascular ATP diphosphohydrolase.

Authors:  E Kaczmarek; K Koziak; J Sévigny; J B Siegel; J Anrather; A R Beaudoin; F H Bach; S C Robson
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor.

Authors:  Evgenia V Gerasimovskaya; Shama Ahmad; Carl W White; Peter L Jones; Todd C Carpenter; Kurt R Stenmark
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

Review 8.  Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade.

Authors:  Gennady G Yegutkin
Journal:  Biochim Biophys Acta       Date:  2008-02-12

Review 9.  Cellular and molecular basis of pulmonary arterial hypertension.

Authors:  Nicholas W Morrell; Serge Adnot; Stephen L Archer; Jocelyn Dupuis; Peter Lloyd Jones; Margaret R MacLean; Ivan F McMurtry; Kurt R Stenmark; Patricia A Thistlethwaite; Norbert Weissmann; Jason X-J Yuan; E Kenneth Weir
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  13 in total

1.  Characterization of ectonucleotidase expression in the rat carotid body: regulation by chronic hypoxia.

Authors:  Shaima Salman; Cathy Vollmer; Grant B McClelland; Colin A Nurse
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

2.  Deregulation of ocular nucleotide homeostasis in patients with diabetic retinopathy.

Authors:  Sirpa Loukovaara; Jouko Sandholm; Kristiina Aalto; Janne Liukkonen; Sirpa Jalkanen; Gennady G Yegutkin
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

3.  Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.

Authors:  Alexander D Verin; Robert Batori; Anita Kovacs-Kasa; Mary Cherian-Shaw; Sanjiv Kumar; Istvan Czikora; Vijaya Karoor; Derek Strassheim; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-20       Impact factor: 4.249

4.  Regulation of CD73 in the development of lower limb atherosclerosis.

Authors:  Juho Jalkanen; Maija Hollmén; Sirpa Jalkanen; Harri Hakovirta
Journal:  Purinergic Signal       Date:  2016-11-10       Impact factor: 3.765

5.  Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities.

Authors:  Gennady G Yegutkin; Bé Wieringa; Simon C Robson; Sirpa Jalkanen
Journal:  FASEB J       Date:  2012-05-25       Impact factor: 5.191

Review 6.  ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.

Authors:  Gennady G Yegutkin; Detlev Boison
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

7.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Extracellular ATP protects endothelial cells against DNA damage.

Authors:  Joonas Aho; Mikko Helenius; Sanna Vattulainen-Collanus; Tero-Pekka Alastalo; Juha Koskenvuo
Journal:  Purinergic Signal       Date:  2016-03-31       Impact factor: 3.765

9.  A venous-specific purinergic signaling cascade initiated by Pannexin 1 regulates TNFα-induced increases in endothelial permeability.

Authors:  Daniela Maier-Begandt; Heather Skye Comstra; Samuel A Molina; Nenja Krüger; Claire A Ruddiman; Yen-Lin Chen; Xiaobin Chen; Lauren A Biwer; Scott R Johnstone; Alexander W Lohman; Miranda E Good; Leon J DeLalio; Kwangseok Hong; Hannah M Bacon; Zhen Yan; Swapnil K Sonkusare; Michael Koval; Brant E Isakson
Journal:  Sci Signal       Date:  2021-03-02       Impact factor: 8.192

10.  Adenosine A1 receptors promote vasa vasorum endothelial cell barrier integrity via Gi and Akt-dependent actin cytoskeleton remodeling.

Authors:  Siddaramappa Nagavedi Umapathy; Nagavedi Siddaramappa Umapathy; Elzbieta Kaczmarek; Nooreen Fatteh; Nana Burns; Rudolf Lucas; Kurt R Stenmark; Alexander D Verin; Evgenia V Gerasimovskaya
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.